Physician profile
Monique M Abrams
NPI 1811378680
$207.06
in general payments reported to CMS, 2019-2025
8 companies · $14.74 in 2025
The $14.74 reported for 2025 was less than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $15.14 · 2021: $18.30 · 2022: $69.75 · 2023: $89.13 · 2025: $14.74.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $104.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aytu Biopharma, INC. | $54.10 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $50.78 | 2022-2023 | Vaxneuvance, Gardasil 9, Vaqta |
| Corium, LLC | $19.96 | 2022 | |
| Neos Therapeutics, LP | $18.12 | 2022 | |
| Seqirus USA INC | $17.22 | 2023 | Flucelvax Quadrivalent |
| Glaxosmithkline, LLC. | $17.00 | 2023 | Bexsero |
| Mallinckrodt Enterprises LLC | $15.14 | 2019 | |
| Amphastar Pharmaceuticals, INC. | $14.74 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Monique Abrams listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.